Clinical Trials Logo

Citation(s)

A Phase 2a Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy, Safety, and Tolerability of KAN-101 In Participants With Celiac Disease

Details for clinical trial NCT06001177